Innovation at Mount Sinai
The Mount Sinai Health System has led the way in health care innovation for more than 130 years, with groundbreaking medical discoveries and technological advancements that improve and save lives.
Our clinicians and scientists are transforming the ways we diagnose, treat, and prevent the conditions that affect our families, friends, and communities.
Now you can partner with us on this most important journey. Join us in the Mount Sinai Ideas Network.
Why Innovate With Mount Sinai?
At Mount Sinai, we innovate every day. Our faculty, students, staff, and strategic external partners are all empowered with the tools needed to translate research from bench to bedside in an innovative and entrepreneurial culture.
More Support, Less Red Tape
At Mount Sinai, innovation is an integral part of our culture. Our combined research and clinical capabilities under a single enterprise reduce bureaucracy and create an agile community where innovators can develop, test, and commercialize their work.
We Connect Innovators to What They Need
Mount Sinai brings people, resources, and programs together into innovation nodes that power and propel transformational innovations.
Works with Mount Sinai innovators and researchers to translate discoveries into widely available products and services. Our Partners
Accelerates the development and delivery of new therapeutic discoveries and develops educational training programs. ConduITS
Improves population health by providing inputs to guide policy and decision-making with a focus on equity and efficiency of care. Department of Population Health
Advances health care innovation to improve and extend lives through medical expertise, digital and biomedical engineering, and data science. Hasso Plattner Institute
At Mount Sinai, our leadership has prioritized innovation and sees it as one of our primary missions as human beings. They are committed to developing health care solutions for diverse populations of patients to make significant improvements in people's lives and communities.
Dennis S Charney, MD
Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai
President for Academic Affairs, Mount Sinai Health System
Scott L Friedman, MD
Dean for Therapeutic Discovery, Icahn School of Medicine at Mount Sinai
Professor of Medicine (Liver Diseases) and Pharmacological Sciences
Erik Lium, PhD
Chief Commercial Innovation Officer, Mount Sinai Health System President, Mount Sinai Innovation Partners
Cynthia Cleto, MSc
Senior Director, Outreach, Entrepreneurship and Special Programs
Mount Sinai Innovation Partners
Mount Sinai inventors have made great strides in diagnostics and therapeutics, including revolutionary advances in medical devices and software. Additionally, technologies developed in our laboratories are powering some of the most groundbreaking startup companies in the world.
Over the last several years, we have added more than a dozen centers and institutes to deliver these innovations faster and more efficiently. This includes the Department of Artificial Intelligence and Human Health, the first such department established by any medical school in the United States.